Cargando…

The Authors Respond

Detalles Bibliográficos
Autores principales:	Xie, Jipan, Namjoshi, Madhav, Parikh, Kejal, Wu, Eric Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2012
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437482/ http://dx.doi.org/10.18553/jmcp.2012.18.1.75

Ejemplares similares

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases
por: Xie, Jipan, et al.
Publicado: (2011)

The Authors Respond
por: Miller, Ross M., et al.
Publicado: (2012)

The Authors Respond
por: Traini, Eugenio, et al.
Publicado: (2022)

The Authors Respond
por: Carlson, Josh J., et al.
Publicado: (2018)

The Authors Respond
por: Hain, Jocelyn
Publicado: (2010)

The Authors Respond:
por: Clay, Patrick
Publicado: (2007)

The Authors Respond
por: Barlow, Stephen
Publicado: (2010)

THE AUTHORS RESPOND
por: Roth, Joshua A., et al.
Publicado: (2020)

The Authors Respond
por: Simpson, Mindy L., et al.
Publicado: (2020)

The Authors Respond
por: Sherrill, Christina H., et al.
Publicado: (2020)

The Authors Respond
por: Le, Quang A., et al.
Publicado: (2020)

THE AUTHORS RESPOND
por: Guzauskas, Gregory F, et al.
Publicado: (2021)

The Authors Respond
por: Touchette, Daniel R., et al.
Publicado: (2020)

The authors respond to criticisms of their model parameters
por: Fisman, David, et al.
Publicado: (2022)

The authors respond to comments from Vermaak and Stahlbrand
por: Nakagawa, Hiroaki, et al.
Publicado: (2021)

The authors respond to: “Delayed discharge and frailty, delirium and functional decline”
por: Jerath, Angela, et al.
Publicado: (2021)

The authors respond to “Concerns about subgroup analyses and reason for stopping remdesivir trial”
por: Murthy, Srinivas
Publicado: (2022)

The authors respond to letters on using prescribed psychostimulants to treat stimulant use disorder
por: Palis, Heather N., et al.
Publicado: (2023)

Re: Comments on “Neuromuscular Ultrasonography of Cranial Nerves”: The Authors Respond
por: Tawfik, Eman A., et al.
Publicado: (2017)

The Author Respond
por: Choi, Jong Sang
Publicado: (2008)

Authors′ reply
por: Parikh, Rajul, et al.
Publicado: (2008)

Author's reply
por: Parikh, Rajul S, et al.
Publicado: (2009)

Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w
por: Song, Jinlin, et al.
Publicado: (2019)

Re: Comments on “Pure or Complex Hereditary Spastic Paraplegia Type 4?”: The Authors Respond
por: Yang, Jiwon, et al.
Publicado: (2019)

Authors' reply
por: Parikh, Mitul, et al.
Publicado: (2009)

The Role of Health Economics and Outcomes Research in Health Care Reform in China
por: Liang, Wannian, et al.
Publicado: (2014)

Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”
por: Erder, M. Haim, et al.
Publicado: (2013)

RE: Comments on "Unilateral Reversible Posterior Leukoencephalopathy Syndrome after Coiling of an Aneurysm": The Authors Respond
por: Huijgen, Willemijn, et al.
Publicado: (2014)

This Issue’s Authors and Panel Respondents
Publicado: (2011)

This Issue’s Authors & Panel Respondents
Publicado: (2004)

This Issue’s Authors & Panel Respondents
Publicado: (2003)

This Issue’s Authors & Panel Respondents
Publicado: (2002)

This Issue’s Authors & Panel Respondents
Publicado: (2007)

This Issue’s Authors & Panel Respondents
Publicado: (2007)

This Issue’s Authors & Panel Respondents
Publicado: (2009)

This Issue’s Authors & Panel Respondents
Publicado: (2008)

The authors respond: monkeypox presentations
por: Brady, William J., et al.
Publicado: (2023)

The Editors Respond
por: Curtiss, Frederic R.
Publicado: (2010)

Responder analyses for anti-amyloid immunotherapies for Alzheimer’s disease: a paradigm shift by regulatory authorities is urgently needed
por: Salemme, Simone, et al.
Publicado: (2023)

This Issue’s Authors, Contributors, & Panel Respondents
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_5ocbafjb1b9pj65q4r6reum2cm